98 related articles for article (PubMed ID: 1350867)
1. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
McLeod MK; Vinik AI
Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
[TBL] [Abstract][Full Text] [Related]
2. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
3. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
[TBL] [Abstract][Full Text] [Related]
4. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
5. [Multiple endocrine neoplasia II A syndrome: relationship between age of the patient, levels of basal calcitonin and size of the thyroid tumor].
Parrilla P; Candel MF; Ponce JL; Tebar J; Albarracin A; Rodriguez JM
Minerva Chir; 1992 May; 47(9):831-8. PubMed ID: 1352395
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors - a report of two cases.
Schneider R; Heverhagen AE; Moll R; Bartsch DK; Schlosser K
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):520-3. PubMed ID: 19691012
[TBL] [Abstract][Full Text] [Related]
8. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
9. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
Meybier H; Schmidt-Gayk H; Buhr H; Raue F
Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail.
Machens A; Haedecke J; Hinze R; Thomusch O; Schneyer U; Dralle H
Dig Surg; 2000; 17(5):522-4. PubMed ID: 11124561
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
12. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
13. Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma.
Libroia A; Verga U; Di Sacco G; Piolini M; Muratori F
Henry Ford Hosp Med J; 1989; 37(3-4):151-3. PubMed ID: 2576951
[TBL] [Abstract][Full Text] [Related]
14. [The determination of calcitonin for hospital use (author's transl)].
Raue F; Minne H; Schäfer D; Ziegler R
MMW Munch Med Wochenschr; 1977 Feb; 119(7):219-24. PubMed ID: 403447
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
16. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
[TBL] [Abstract][Full Text] [Related]
17. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
[TBL] [Abstract][Full Text] [Related]
18. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
[TBL] [Abstract][Full Text] [Related]
19. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
20. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
